- Jan 31
Understanding How Childhood Brain Tumors Develop
A team of scientists has identified a new cell type implicated in the development of the most common type of malignant childhood brain tumor, according to a study published in Nature. Read more: https://news.feinberg.northwestern.edu/2023/01/23/understanding-how-childhood-brain-tumors-develop/
- Jan 30
American Academy of Pediatrics Issues New Recommendations on Hospitalized Adolescents
The American Academy of Pediatrics has published new recommendations on the needs of adolescents who are hospitalized within its first policy statement on the topic, which is published in the February 2023 issue of Pediatrics. Read more: https://www.aap.org/en/news-room/news-releases/aap/2022/american-academy-of-pediatrics-issues-new-recommendations-on-hospitalized-adolescents/
- Jan 27
Genes that cause rare hidden cancer revealed
Several genes that cause sarcoma have been identified in the first comprehensive genetic map of sarcomas. The research has wide implications for people living with sarcoma and their families -- allowing detection of the cancer earlier and potentially improving survival for patients. Read more: https://www.sciencedaily.com/releases/2023/01/230119141536.htm
- Jan 26
Stopping a rare childhood cancer in its tracks
Scientists at Cold Spring Harbor Laboratory (CSHL) have discovered a new drug target for Ewing sarcoma, a rare kind of cancer usually diagnosed in children and young adults. Their experiments show that the cells causing this cancer can essentially be reprogrammed with the flick of a genetic switch. Read more: https://medicalxpress.com/news/2023-01-rare-childhood-cancer-tracks.html
- Jan 25
Pediatric Cancer Vaccine May Be ‘Too Good to Be True,’ But More Work Is Needed
Ongoing trials are showing that a cancer vaccine may be able to overcome some of the other issues that are present with immune-based cancer treatments like checkpoint inhibition and CAR-T cell therapy, in children. Read more: https://www.curetoday.com/view/pediatric-cancer-vaccine-may-be-too-good-to-be-true-but-more-work-is-needed
- Jan 24
New research identifies a potential treatment target for hepatoblastoma in children
In a novel study appearing in The American Journal of Pathology, investigators studying a mouse model of hepatoblastoma report that the protein heat shock transcription factor 1 (HSF1) is needed for aggressive tumor growth and may be a viable pharmacologic target for hepatoblastoma treatment. Read more: https://medicalxpress.com/news/2023-01-potential-treatment-hepatoblastoma-common-liver.html
- Jan 23
Loneliness May Lead to Chronic Conditions Emotional Distress in Young Adult Cancer Survivors
Young adult childhood cancer survivors may have an increased risk for loneliness, which may be linked to new-onset chronic conditions and future emotional distress, according to recent study results. Read more: https://www.curetoday.com/view/loneliness-may-lead-to-chronic-conditions-emotional-distress-in-young-adult-childhood-cancer-survivors
- Jan 20
Canadian Pediatric Cancer Consortium launches to advance research in paediatric cancer care
Cancer is the leading cause of death from disease in children and adolescents in Canada, with 1,500 children newly diagnosed each year. In an important milestone for Canadian paediatric cancer care and research, the Canadian Institutes of Health Research (CIHR) today announced $23 million in funding to establish the Canadian Pediatric Cancer Consortium (CPCC). Read more: https://www.sickkids.ca/en/news/archive/2023/canadian-pediatric-cancer-consortium-launches-to-advance
- Jan 19
Oncological emergencies: A must know condition for families with childhood cancer
Oncological emergencies are defined as any acute, morbid or life-threatening events among children suffering from cancer which are caused either due to the malignancy or due to the treatment. Such emergencies can develop any time throughout malignancy – from initial symptoms to the end stage of the disease. Read more: https://timesofindia.indiatimes.com/blogs/voices/oncological-emergencies-a-must-know-condition-for-families-with-childhood-cancer/
- Jan 18
Colin Seaman is the boy with the Harry Potter cells
"While developing a treatment plan, Lee introduced the family to a revolutionary treatment option for some patients with leukemia. Colin was a candidate for this new treatment, one that uses the body’s own T-cells, part of the body’s immune system, to fight the disease. The first therapy developed using this revolutionary technology was approved in 2017. Since then, five other therapies have been approved, all for cancers of the blood." Read more: https://dailyprogress.